Some patients with interstitial lung disease (ILD) have a fibrotic phenotype. Some of these patients respond – at least in the short term – to therapy. In some cases, however, the disease continues to progress despite treatment. What is the appropriate option under which circumstances has been formulated in new guidelines.
This content is machine-translated. Please contact us if you need professional translation services.
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
- HAUSARZT PRAXIS
